Kevin G. Byrnes - Nov 11, 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Nov 11, 2021
Transactions value $
-$1,031,230
Form type
4
Date filed
11/15/2021, 07:10 PM
Previous filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise $77.4K +2.92K +35.77% $26.52 11.1K Nov 11, 2021 Direct
transaction MED Common Stock Options Exercise $158K +5K +45.16% $31.55 16.1K Nov 11, 2021 Direct
transaction MED Common Stock Options Exercise $138K +5K +31.11% $27.68 21.1K Nov 11, 2021 Direct
transaction MED Common Stock Tax liability -$1.4M -6.15K -29.18% $228.45 14.9K Nov 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Stock Options Options Exercise $0 -2.92K -100% $0.00* 0 Nov 11, 2021 Common Stock 2.92K $26.52 Direct F2
transaction MED Stock Options Options Exercise $0 -5K -100% $0.00* 0 Nov 11, 2021 Common Stock 5K $31.55 Direct F3
transaction MED Stock Options Options Exercise $0 -5K -100% $0.00* 0 Nov 11, 2021 Common Stock 5K $27.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a withholding of 6,149 shares of the Issuer's common stock to satisfy the exercise price and the tax obligation in connection with the exercise of certain stock options.
F2 These options vested in three equal annual installments beginning on February 5, 2015.
F3 These options vested in three equal annual installments beginning on February 17, 2016.
F4 These options vested in three equal annual installments beginning on February 4, 2017.